가다실 9과 가다실 4의 차이점은 무엇인가요?

가다실 4가는 HPV 아형 6, 11, 16, 18형에 대해 예방 효과를 제공합니다. 가다실 9가는 동일한 4가지 아형에 더해 HPV 31, 33, 45, 52, 58형의 5가지 아형을 추가로 방어하여 더욱 넓은 범위의 예방 범위를 제공합니다.

가다실 9는 가다실 4에 비해 자궁경부암 예방에 얼마나 효과적입니까?

가다실 4는 자궁경부암에 대해 약 70%의 예방 효과를 제공하는 반면, 가다실 9는 약 90%의 예방 효과를 제공하여 예방 범위가 크게 확대되었습니다.

가다실은 남성에게 음경암을 예방하나요?

현재의 증거에 따르면 가다실 백신은 남성에게도 HPV 예방 효과를 제공하며 음경암에 대해 어느 정도의 이점이 있지만, 기존 문헌에 따르면 남성의 비용 대비 효과는 여성보다 낮은 것으로 간주됩니다.

가다실 4가는 생식기 사마귀 예방에 얼마나 효과적입니까?

가다실 4는 생식기 사마귀에 대해 약 77%의 예방 효과를 제공하는 것으로 보고되었습니다. 가다실 9는 더 뛰어난 예방 효과를 제공할 것으로 예상되지만, 생식기 사마귀에 대한 가다실 9의 최신 유효성 데이터는 아직 발표되지 않았습니다.

가다실 백신 3회 접종을 모두 마치기 전에 첫 번째 접종만으로도 어느 정도 보호 효과를 얻을 수 있나요?

네. 2017년 스페인에서 실시된 한 연구에 따르면, 가다실 4를 1회 접종했을 때 약 61%의 예방 효과가 있는 것으로 나타났습니다. 하지만 이러한 부분적인 예방 효과가 얼마나 오래 지속되는지는 명확하지 않으므로, 0개월, 2개월, 6개월에 걸쳐 총 3회 접종을 완료하는 것이 여전히 권장됩니다.

가다실 백신은 이미 HPV에 감염되었더라도 여전히 효과를 얻을 수 있나요?

Yes. A large study of 18,174 women published in 2009 confirmed that Gardasil still provides meaningful protection against other HPV subtypes even in patients who have had a prior HPV infection.

Is Gardasil 9 worth the extra cost compared to Gardasil 4?

Gardasil 9 is more expensive than Gardasil 4 but offers broader protection against 9 HPV subtypes versus 4, and higher efficacy against cervical cancer (90% vs 70%). Whether it is worth the additional cost depends on individual circumstances — discuss with your urologist or doctor.

가다실 9 vs 가다실 4: 어떤 HPV 백신?

마지막 업데이트: 8월 15, 2026

소아라위 위라소폰, 비뇨기과 전문의

방콕 병원 본부, 방콕

사미티벳 스라차 병원 — 비뇨기과: 088-022-1445

진료 예약

내 사무실에 있는 많은 환자들이 이러한 HPV 예방 접종, Gardasil 9 및 Gardasil 4의 차이점에 대해 질문했을 때. 이 기사에서는 이러한 모든 질문에 대한 자세한 답변을 제공합니다.

Several gentlemen have questions on Gardasil 9 vaccination.

Gardasil 9 FAQ

Which HPV subtypes are covered?

Gardasil 4: covers HPV 6, 11, 16, and 18.
Gardasil 9: covers HPV 6, 11, 16, 18, 31, 33, 45, 53, and 58 — 5 additional high-risk strains.

Protection rate against cervical cancer?

Gardasil 4: approximately 70% protection.
Gardasil 9: approximately 90% protection.

Gardasil 9 can protect men against penile cancer and genital warts.

Protection against genital warts?

Gardasil 4: approximately 77% protection.
Gardasil 9: expected to provide higher protection, though updated efficacy data for genital warts is still pending.

Can partial vaccination (1 jab) provide protection?

Yes. A 2017 Spanish study showed 61% protection after just 1 Gardasil-4 injection, though the duration of this partial protection is unclear. A complete 3-dose course (at 0, 2, and 6 months) is still recommended for maximum protection.

Can previously HPV-infected patients still benefit from vaccination?

Yes. A 2009 study of 18,174 women showed Gardasil still provides significant protection even in those with prior HPV infection, as vaccination protects against strains not previously encountered.

Patients still get benefit from Gardasil 9 even with previous HPV infection history.

Gardasil 9 is a bit more costly than Gardasil 4, but offers significantly broader protection. Any question, talk to your trusted urologist, or it would be my honor if you text me. Take care!

내 공식 웹 사이트를 방문 할 수 있습니다 여기.

자주 묻는 질문 (FAQ)

Q1: What is the main difference between Gardasil 9 and Gardasil 4?

Gardasil 9 covers 9 HPV strains (6, 11, 16, 18, 31, 33, 45, 53, 58) while Gardasil 4 covers only 4 strains (6, 11, 16, 18). The 5 additional strains in Gardasil 9 are high-risk cancer-causing types. This broader coverage translates into approximately 90% protection against cervical cancer with Gardasil 9 versus approximately 70% with Gardasil 4, making Gardasil 9 the superior choice where available.

Q2: Should men get the Gardasil HPV vaccination?

Yes. While HPV vaccination is most studied and cost-effective in females, men can still benefit significantly. HPV vaccination in men reduces the risk of penile cancer, anal cancer, oropharyngeal cancer, and genital warts. HPV strains 6 and 11 (covered by both Gardasil 4 and 9) cause approximately 90% of genital warts cases. Vaccination before first sexual exposure offers the highest protection.

Q3: How many doses of Gardasil are needed?

A complete HPV vaccination course consists of 3 injections given at 0, 2, and 6 months. For individuals aged 9-14 who start the series early, a 2-dose schedule may be sufficient. Even a single dose provides some protection (approximately 61% based on Gardasil-4 data), but completing the full course is strongly recommended for maximum and most durable protection.

Q4: Is it worth getting Gardasil 9 if I have already been infected with HPV?

Yes. Even if you have had a prior HPV infection, vaccination still provides significant benefit by protecting against HPV strains you have not yet been exposed to. A landmark 2009 study of over 18,000 women confirmed that Gardasil provides meaningful protection even in individuals with prior HPV infection. Your urologist can advise whether vaccination is appropriate based on your specific HPV history.

Q5: Is Gardasil 9 worth the higher cost compared to Gardasil 4?

In most clinical settings, yes. The additional 20% improvement in cervical cancer protection (90% vs 70%) and coverage of 5 extra high-risk HPV strains make Gardasil 9 the preferred choice from a medical standpoint. While Gardasil 9 is more expensive, the broader protection against cancer-causing strains represents significant long-term health value. Your doctor can help you make an informed decision based on your individual risk profile and budget.

If you would like to discuss HPV vaccination or sexual health screening, Dr. Soarawee Weerasopone offers specialist consultations at Bangkok Hospital Headquarters. 진료 예약.

면책 조항: 본 내용은 방콕 병원 본사의 전문의인 Soarawee Weerasopone 박사가 작성하고 검토한 것입니다. 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 모든 의학적 치료를 시작하기 전에 항상 자격을 갖춘 의료 전문가와 상담하십시오.

의학적으로 작성 및 검토됨: Dr. Soarawee Weerasopone (Dr. Pom) — Board-Certified Urologist, Bangkok Hospital Headquarters, in urological practice since 2016. Fellowship: Robotic Surgery, Chang Gung Memorial Hospital, Taiwan (2019) · Observership: Endourology, Juntendo University Hospital, Tokyo (2022) · Research Scholar & Clinical Observer, Scott Department of Urology, Baylor College of Medicine, USA (2025–2026).

소아라위 위라소폰 박사

Dr. Soarawee Weerasopone (Dr. Pom) is a board-certified urologist at Bangkok Hospital Headquarters, specializing in Men’s Health, Robotic Surgery (da Vinci Xi) and Kidney Stone treatment. He is currently a Research Scholar and Clinical Observer at the Scott Department of Urology, Baylor College of Medicine (2025–2026), under Prof. Mohit Khera. He completed a Robotic Surgery Fellowship at Chang Gung Memorial Hospital, Taiwan (2019) and an Endourology Observership at Juntendo University Hospital, Tokyo (2022).